BSECompany UpdateResults27 Oct 2026
NIIT Ltd
Link of audio recording of Investors call held on October 27, 2026
NIIT Ltd has announced the link to the audio recording of its investors call held on October 27, 2026, to discuss the unaudited financial results for the quarter and half year ended September 30, 2026.
NSEUpdatesResults27 Oct 2026
Capri Global Capital Limited
Updates
Capri Global Capital Limited has informed the Exchange regarding Security Cover Certificate as at September 30, 2026 for Debt Listed on BSE.
BSEBoard MeetingResults27 Oct 2026
PB Fintech Ltd
PB Fintech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, along with the limited review report of the Auditors thereon
PB Fintech Ltd has scheduled a Board Meeting on October 30, 2026, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
BSEResultResults27 Oct 2026
Kkalpana Plastick Ltd
Please find attached the Un-Audited Financial Results of the company for the 02nd quarter and half-year ended 30th September, 2026
Kkalpana Plastick Ltd has announced its un-audited financial results for the 2nd quarter and half-year ended September 30, 2026. The company has also completed its open offer and Ashish Begwani will acquire control over the company. The board has approved the appointments of new directors and key managerial personnel, and has accepted the resignations of existing directors and key managerial personnel.
NSEOutcome of Board MeetingResults27 Oct 2026
United Breweries Limited
Outcome of Board Meeting
United Breweries Limited has announced its unaudited standalone and consolidated financial results for the quarter and year to date ended September 30, 2026, with a profit for the period/year of Rs. 30,232 lakhs.
NSEIntegrated Filing- FinancialResults27 Oct 2026
Star Health and Allied Insurance Company Limited
Integrated Filing- Financial
Star Health and Allied Insurance Company Limited has filed its integrated financial results for the quarter and half year ended September 30, 2026.
BSEBoard MeetingResults27 Oct 2026
Choice International Ltd
Choice International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026 and to consider the proposal for Bonus issue to the equity shareholders of the Company subject to the requisite approvals.
Choice International Ltd has scheduled a board meeting on November 2, 2026, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026, and to consider a proposal for a bonus issue to equity shareholders.
BSEBoard MeetingResults27 Oct 2026
Star Health and Allied Insurance Company Ltd
Star Health and Allied Insurance Company Limited ('Company'), in their meeting held on Tuesday, October 27, 2026 inter alia, had considered and approved the unaudited standalone financial results of the company for the quarter and half year ended September 30, 2026
Star Health and Allied Insurance Company Limited has announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors in their meeting held on October 27, 2026. The results include a Limited Review Report issued by the Joint Statutory Auditors.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
BSECompany Update▲ PositiveResults27 Oct 2026
Piramal Pharma Ltd
Please find enclosed Investor presentation for quarter ended 30 September, 2026
Piramal Pharma Ltd announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
NSEInvestor Presentation▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Investor Presentation
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
BSEBoard MeetingResults27 Oct 2026
Euro Pratik Sales Ltd
Euro Pratik Sales Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026.
Euro Pratik Sales Ltd has scheduled a Board Meeting on 05/11/2026 to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September, 2026.
NSEPress Release▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Press Release
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
BSECompany Update▲ PositiveResults27 Oct 2026
Piramal Pharma Ltd
Please find enclosed Press release for quarter ended 30 September, 2026
Piramal Pharma Ltd has announced its unaudited financial results for Q2 and H1 FY27, with revenue growth of 28% YoY and 23% YoY respectively, driven by strong performance across all three businesses. EBITDA increased 72% YoY in Q2FY27 and H1FY27, with over 350bps EBITDA margin expansion in both periods.
BSEResultResults27 Oct 2026
Madhav Infra Projects Ltd
Intimation of Unaudited Standalone & Consolidated Financial Results along with Limited Review Report for the Quarter & Half Year ended on September 30, 2026.
Madhav Infra Projects Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report from its statutory auditors. The company has drawn attention to a non-ascertainment and non-provision of Deferred Tax Liability as per Ind AS 12 Income Taxes.
BSEResultResults27 Oct 2026
Star Health and Allied Insurance Company Ltd
Star Health and Allied Insurance Company Limited has informed the exchanges regarding declaration of unaudited standalone financial results of the Company for the quarter and half year ended September 30,2026.
Star Health and Allied Insurance Company Ltd has declared unaudited standalone financial results for the quarter and half year ended September 30, 2026, and reclassified Sthitaprajna Advisors LLP from Promoter Group Category to Public Shareholder Category.
NSEOutcome of Board MeetingResults27 Oct 2026
Star Health and Allied Insurance Company Limited
Outcome of Board Meeting
Star Health and Allied Insurance Company Limited has submitted its financial results for the period ended September 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults27 Oct 2026
Zee Entertainment Enterprises Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Zee Entertainment Enterprises Limited has informed the Exchange about a Board meeting on October 30, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026, and will hold a conference with investors on the same day.
NSEOutcome of Board MeetingResults27 Oct 2026
Piramal Pharma Limited
Outcome of Board Meeting
Piramal Pharma Limited has submitted its financial results for the period ended September 30, 2026.
BSECompany UpdateResults27 Oct 2026
Advait Energy Transitions Ltd
Earnings call intimation post announcement of unaudited standalone and consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 is scheduled on November 2, 2026
Advait Energy Transitions Ltd has announced an earnings call for Q2/H1-FY26 results, scheduled on November 2, 2026, at 11:00 a.m. IST.